产品详情
Targets
Target | Value |
---|---|
Akt2 | IC50: 17nM |
PKA | IC50: 20nM |
Akt1 | IC50: 32nM |
Akt3 | IC50: 47nM |
p70S6K | IC50: 85nM |
RSK1 | IC50: >100nM |
CDK2 | IC50: >1μM |
GSK-3β | IC50: >1μM |
c-Src | IC50: >1μM |
Chk1 | IC50: >1μM |
EGFR | IC50: >1μM |
FGFR3 | IC50: >1μM |
MEK1 | IC50: >1μM |
PDK-1 | IC50: >1μM |
PI3Kβ | IC50: >1μM |
PLK3 | IC50: >1μM |
RET | IC50: >1μM |
SGK | IC50: >1μM |
Tie-2 | IC50: >1μM |
In vitro (25°C) | DMSO | 63 mg/mL (186.47 mM) | |
Water | Insoluble | ||
Ethanol | 5 mg/mL (14.79 mM) | ||
In vivo | 15% Captisol, pH 9 | 9 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 29.59 mL | 147.97 mL | 295.95 mL |
0.5 mM | 5.92 mL | 29.59 mL | 59.19 mL |
1 mM | 2.96 mL | 14.8 mL | 29.59 mL |
5 mM | 0.59 mL | 2.96 mL | 5.92 mL |
*The above data is based on the productmolecular weight 337.9 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10094 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 337.9 |
Formula | C20H20ClN3 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 857531-00-1 |
Synonyms | AT-7867 |
SMILES | C1CNCCC1(C2=CC=C(C=C2)C3=CNN=C3)C4=CC=C(C=C4)Cl |
产品标签
Product Questions
Product Questions
Akt1 and Akt2-IN-1
Akt1 and Akt2-IN-1是Akt1(IC50 = 3.5 nM)和Akt2(IC50 = 42 nM)的变构抑制剂,具有有效且平衡的活性。
Perifosine (NSC-639966)
Perifosine (也为KRX-0401) 充当Akt抑制剂和PI3K抑制剂。
Triciribine
Triciribine,也称为API-2,可抑制Akt的磷酸化水平和激酶活性。
Triciribine phosphate (NSC-280594)
Triciribine phosphate是一种DNA synthesis抑制剂,也抑制PC3细胞系中的Akt和CEM-SS,H9,H9IIIB,U1细胞中的HIV-1,IC50分…